Risk factors of liver metastasis from advanced pancreatic adenocarcinoma: a large multicenter cohort study.

World J Surg Oncol 2017 Jul 3;15(1):120. Epub 2017 Jul 3.

Digestive Endoscopy Center, Department of Gastroenterology, Changhai Hospital, The Second Military Medical University, 169 Changhai Road, 200433, Shanghai, China.

Background: Clinical prognostic parameters of liver metastasis from pancreatic adenocarcinoma have not been specifically identified.This study is to explore the risk factors of liver metastasis in advanced pancreatic adenocarcinoma (PDAC) patients in China.

Methods: A multicenter cohort study was conducted to explore whether liver metastasis in locally advanced and metastatic PDAC could be reflected by some common laboratory indexes. We collected 1787 advanced PDAC patients from three participating hospitals between 2004 and 2014. The associations between some laboratory indexes and risks of liver metastases were analyzed.

Results: Results have shown that 87% of stage IV patients developed synchronous liver metastasis. Primary tumor location (body/tail vs. head/neck, OR 0.55, 95% CI 0.36-0.83), primary tumor diameter (≥20 mm vs. <20 mm, OR 1.77, 95% CI 1.16-2.70), elevated ALT and AST (OR 1.62, 95% CI 0.92-2.83), and elevated CA19-9 (OR 2.72, 95% CI 1.85-3.99) upon diagnosis are significantly associated with risk of synchronous liver metastasis. Among stage III patients, 30.1% developed metachronous liver metastasis. However, no risk factors were identified among these patients.

Conclusions: Primary tumor location, diameter, elevated ALT and AST, and increased CA19-9 are independent risk factors of synchronous liver metastasis in PDAC patients.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12957-017-1175-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496221PMC
July 2017
69 Reads
1 Citation
1.200 Impact Factor

Publication Analysis

Top Keywords

liver metastasis
20
pancreatic adenocarcinoma
12
advanced pancreatic
8
laboratory indexes
8
pdac patients
8
cohort study
8
multicenter cohort
8
metastasis advanced
8
risk factors
8
factors liver
8
primary tumor
8
liver
6
metastasis
5
three participating
4
participating hospitals
4
2014 associations
4
indexes risks
4
associations laboratory
4
patients three
4
2004 2014
4

References

(Supplied by CrossRef)

R Spadi et al.
World J Clin Oncol 2016

Y Yuan et al.
Chem Biol 2013

RJ Torphy et al.
PLoS ONE 2014

S Manfredi et al.
Ann Surg 2006

G Wiltberger et al.
BMC Surg 2015

O Bouglouga et al.
Med Sante Trop 2015

S Manfredi et al.
Ann Surg 2006

WW Ng et al.
Asian J Surg 2009

Similar Publications